Validation of the lung immune prognostic index (LIPI) in patients with metastatic renal cell carcinoma treated with nivolumab in the GETUG-AFU 26 NIVOREN trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreValidation of the lung immune prognostic index (LIPI) in patients with metastatic renal cell carcinoma treated with nivolumab in the GETUG-AFU 26 NIVOREN trial
Type de publicationJournal Article
Year of Publication2020
AuteursLavaud P, Dalban C, Negrier S, Chevreau C, Gravis G, Oudard S, Laguerre B, Barthelemy P, Borchiellini D, Goupil MGross, Geoffrois L, Rolland F, Thiery-Vuillemin A, Joly F, Ladoire S, Tantot F, Mezquita L, Escudier B, Albiges L
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume38
Date PublishedFEB 20
Type of ArticleMeeting Abstract
ISSN0732-183X